Veracyte revenue increased from $92 million in 2018 to $120.4 million in 2019, a (30.8%) increase.

Annual Revenue ($)

Veracyte revenue was $120.37 m in FY, 2019 which is a (30.8%) year over year increase from the previous period.

Quarterly Revenue ($)

FY, 2017FY, 2018FY, 2019
Revenue$71.95 m$92.01 m$120.37 m
Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020
Revenue$20.04 m$22.75 m$23.47 m$29.53 m$30.14 m$30.97 m$31.12 m$20.7 m$31.12 m

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Veracyte revenue breakdown by business segment: 89.2% from Testing Revenue, 6.7% from Biopharmaceutical Revenue and 4.1% from Other

FY, 2019FY, 2018
Testing Revenue$107.36 m$91.06 m
Biopharmaceutical Revenue$8.09 m$950 k
Product Revenue$923 k
Collaboration Revenue$4 m

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu